HPRA Drug Safety Newsletter Edition 87
Download:
hpra-drug-safety-newsletter-edition-87.pdf
174 KB
The latest edition of the HPRA Drug Safety Newsletter (DSN) includes an important update to support the safe and appropriate use of valproate-containing medicines (licensed as Epilim in Ireland).
Valproate (Epilim) - New contraindication, strengthened warnings and measures to prevent exposure during pregnancy
« Back